Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Colorcon
Mallinckrodt
US Department of Justice
US Army
Covington
Baxter
Healthtrust
Julphar

Generated: February 21, 2019

DrugPatentWatch Database Preview

AVONEX Drug Profile

« Back to Dashboard

Summary for Tradename: AVONEX
Patents:73
Applicants:1
BLAs:1
Suppliers: see list1
Drug Prices: Drug price information for AVONEX

US Patents for AVONEX

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Pathologica LLC (San Francisco, CA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Avalyn Pharma Inc. (Seattle, WA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Tularik Inc. (South San Francisco, CA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Board of Regents, University of Texas System (Austin, TX) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for AVONEX

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
92513 Luxembourg ➤ Sign Up PRODUCT NAME: SOFOSBUVIR ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (SOVALDI). FIRST REGISTRATION: 20140117
CA 2014 00041 Denmark ➤ Sign Up PRODUCT NAME: SOFOSBUVIR; REG. NO/DATE: EU/1/13/894/001-002 20140116
CA 2016 00058 Denmark ➤ Sign Up PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
93315 Luxembourg ➤ Sign Up PRODUCT NAME: PROCEDE DE TRAITEMENT DE LA SCLEROSE MULTIPLE - DACLIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/16/1107
PA2014031 Lithuania ➤ Sign Up PRODUCT NAME: SOFOSBUVIRUM; REGISTRATION NO/DATE: EU/1/13/894/1, 2014 01 16 EU/1/13/894/2 20140116
300845 Netherlands ➤ Sign Up PRODUCT NAME: DADIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
CR 2016 00058 Denmark ➤ Sign Up PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Express Scripts
Fuji
Julphar
Chinese Patent Office
Moodys
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.